Literature DB >> 3289204

Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months.

J Dupré1, C R Stiller, M Gent, A Donner, B von Graffenreid, G Murphy, D Heinrichs, M R Jenner, P A Keown, A Laupacis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3289204

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

Review 1.  Emerging indications for the use of cyclosporin in organ transplantation and autoimmunity.

Authors:  P A Keown
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 2.  The epidemiology of diabetes in childhood with special reference to the Orient: implications for mechanism of beta cell damage.

Authors:  A L Drash; N Cho; N Tajima; M Rewers; R Laporte
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

Review 3.  Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Authors:  Scott J Pilla; Amy Q Quan; Emily L Germain-Lee; David B Hellmann; Nestoras N Mathioudakis
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

4.  Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.

Authors:  F Nicoletti; P Zaccone; R Di Marco; G Magro; S Grasso; S Morrone; A Santoni; G Tempera; P L Meroni; K Bendtzen
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

Review 5.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

6.  Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.

Authors:  S Martin; G Schernthaner; J Nerup; F A Gries; V A Koivisto; J Dupré; E Standl; P Hamet; R McArthur; M H Tan
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

7.  Cyclosporin A treatment of young children with newly-diagnosed type 1 (insulin-dependent) diabetes mellitus. London Diabetes Study Group.

Authors:  M Jenner; G Bradish; C Stiller; P Atkison
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

Review 8.  Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.

Authors:  Sofie Robert; Hannelie Korf; Conny Gysemans; Chantal Mathieu
Journal:  Islets       Date:  2013-03-01       Impact factor: 2.694

9.  The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin.

Authors:  G Papaccio; M Latronico; G Chieffi Baccari
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

Review 10.  Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case.

Authors:  Sofie Robert; Lothar Steidler
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.